Old Web
English
Sign In
Acemap
>
Paper
>
49. Five-year safety and efficacy of velaglucerase alfa in Gaucher disease type 1: Experience in clinic and home settings
49. Five-year safety and efficacy of velaglucerase alfa in Gaucher disease type 1: Experience in clinic and home settings
2010
Deborah Elstein
Ari Zimran
Gabriel M. Cohn
Kiran Bhirangi
Keywords:
Velaglucerase alfa
Physical therapy
Disease
Biology
Genetics
Diabetes mellitus
Pediatrics
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]